IXICO PLC
Research IXICO PLC (IXI) on Bullrun: market cap GBX 1.64B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIXI
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyGBX
- Market capGBX 1.64B
- Financial periodFY2025
- RevenueGBP 6.53M
- Revenue growth13.3%
- Net income-GBP 1.65M
- Free cash flow-GBP 1.88M
- Gross margin48.7%
Valuation Snapshot
latest market cap is GBX 1.64B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 6.53M | -GBP 1.65M | -GBP 1.88M | 48.7% | n/a | GBP 3.54M | GBP 179.00K | GBP 11.74M |
| FY2024 | GBP 5.77M | -GBP 2.00M | -GBP 2.20M | 47.0% | -0.04 | GBP 1.79M | GBP 314.00K | GBP 9.46M |
| FY2023 | GBP 6.67M | -GBP 1.18M | -GBP 1.66M | 49.1% | -0.02 | GBP 4.03M | GBP 387.00K | GBP 11.43M |
| FY2022 | GBP 8.64M | GBP 1.03M | -GBP 821.00K | 60.7% | 0.02 | GBP 5.77M | GBP 516.00K | GBP 12.49M |
| FY2021 | n/a | n/a | n/a | n/a | 0.03 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | GBX 1.64B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About IXICO PLC
IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is IXICO PLC's market cap?
IXICO PLC's market capitalization is GBX 1.64B.
What does IXICO PLC do?
IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services.